Pinetree Therapeutics Closes $17 Million in Series A Funding to Advance AbReptor™ Protein Degradation Platform and Portfolio Programs

Get in touch

Contact us for more information about how we can help you invest in healthcare, biotech, climate tech, or advanced systems.